NCT07496450: A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
- State
- Under way
- Phase
- Phase 3
- People
- 4,050 taking part
- Started
- 23 Mar 2026
- Primary completion
- 28 Jan 2027
- Arms
- mRNA-1018-H5 Vaccine
- Results
- None posted
- 23 Mar 2026: Trial started
- 27 Mar 2026: Trial registered